Bob Dagher
Technik-/Wissenschafts-/F&E-Leiter bei BRAINSTORM CELL THERAPEUTICS INC.
Vermögen: 134 596 $ am 30.04.2024
Aktive Positionen von Bob Dagher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.04.2024 | - |
Corporate Officer/Principal | 17.07.2023 | 16.04.2024 |
Karriereverlauf von Bob Dagher
Ehemalige bekannte Positionen von Bob Dagher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENVERIC BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.12.2021 | 01.01.2023 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.12.2019 | 01.12.2021 |
COVANCE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | 01.01.2019 |
MedAvante-ProPhase, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Bob Dagher
Université de Bordeaux | Undergraduate Degree |
Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Frankreich | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
ENVERIC BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
MedAvante-ProPhase, Inc. |
- Börse
- Insiders
- Bob Dagher
- Erfahrung